US FDA declines to approve Vanda's stomach condition drug
Vanda Pharmaceuticals said on Thursday the U.S. Food and Drug Administration declined to approve its drug to treat a type of ...
U.S. FDA declines to approve Vanda's stomach paralysis drug
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
FDA rejects Vanda Pharmaceuticals' application to bring key drug to market
A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...
The Christian Post2h
Georgia abortion law not responsible for deaths of Amber Thurman and Candi Miller, pro-life doctors say
Georgia s abortion law is not responsible for the deaths of Amber Thurman and Candi Miller, according to pro-life medical ...
The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
FDA Expands Use of Breast Cancer Drug Kisqali
Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the ...
US FDA approves Eli Lilly's drug for eczema
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...
Lexicon Pharmaceuticals President and COO Jeffrey Wade to step down
Another Houston-area executive is stepping down in the wake of recent successes but also layoffs announced last month.
TRUTH in Labeling Act would heighten the warning for shoppers looking to cut sugar, salt and saturated fat intake
If the legislation passes, the new label would be centered on the front of the package. But it’s an add-on, not a replacement ...
Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the FDA ...
policymed.com13h
Protecting Patients from Deceptive Drug Ads Online Act Introduced
Senators Dick Durbin of Illinois and Mike Braun of Indiana recently introduced bipartisan legislation aimed at closing ...